Style | Citing Format |
---|---|
MLA | Setayesh L, et al.. "The Impact of Emblica Officinalis (Amla) on Lipid Profile, Glucose, and C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomized Controlled Trials." Diabetes and Metabolic Syndrome: Clinical Research and Reviews, vol. 17, no. 3, 2023, pp. -. |
APA | Setayesh L, Haghighat N, Rasaei N, Rezaei M, Casazza K, Nadery M, Yamrali I, Zamani M, Asbaghi O (2023). The Impact of Emblica Officinalis (Amla) on Lipid Profile, Glucose, and C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 17(3), -. |
Chicago | Setayesh L, Haghighat N, Rasaei N, Rezaei M, Casazza K, Nadery M, Yamrali I, Zamani M, Asbaghi O. "The Impact of Emblica Officinalis (Amla) on Lipid Profile, Glucose, and C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomized Controlled Trials." Diabetes and Metabolic Syndrome: Clinical Research and Reviews 17, no. 3 (2023): -. |
Harvard | Setayesh L et al. (2023) 'The Impact of Emblica Officinalis (Amla) on Lipid Profile, Glucose, and C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 17(3), pp. -. |
Vancouver | Setayesh L, Haghighat N, Rasaei N, Rezaei M, Casazza K, Nadery M, et al.. The Impact of Emblica Officinalis (Amla) on Lipid Profile, Glucose, and C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2023;17(3):-. |
BibTex | @article{ author = {Setayesh L and Haghighat N and Rasaei N and Rezaei M and Casazza K and Nadery M and Yamrali I and Zamani M and Asbaghi O}, title = {The Impact of Emblica Officinalis (Amla) on Lipid Profile, Glucose, and C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomized Controlled Trials}, journal = {Diabetes and Metabolic Syndrome: Clinical Research and Reviews}, volume = {17}, number = {3}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Setayesh L AU - Haghighat N AU - Rasaei N AU - Rezaei M AU - Casazza K AU - Nadery M AU - Yamrali I AU - Zamani M AU - Asbaghi O TI - The Impact of Emblica Officinalis (Amla) on Lipid Profile, Glucose, and C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomized Controlled Trials JO - Diabetes and Metabolic Syndrome: Clinical Research and Reviews VL - 17 IS - 3 SP - EP - PY - 2023 ER - |